News World Europe set to approve COVID-19 vaccine in Christmas week

Europe set to approve COVID-19 vaccine in Christmas week

Europeans are set to start getting coronavirus vaccines before the new year after the regional drug regulator accelerated its approval process following the launch of immunisation campaigns in the United States and Britain.

The European Medicines Agency (EMA) said an expert panel would convene on Monday, Dec. 21, to evaluate the vaccine made by U.S. company Pfizer and German partner BioNTech. It had previously said the meeting could be as late as Dec 29.

While EMA’s mandate is to issue recommendations on new medical treatments, the European Commission has the final say on approval and typically follows EMA’s advice.

EMA said its expert meeting was brought forward after the companies had provided more data, as requested, and the EU Commission would fast-track its procedures to rule on approval “within days”.

Germany should start giving coronavirus shots 24 to 72 hours after the BioNTech/Pfizer vaccine gets EU approval and could begin as soon as Christmas, Health Minister Jens Spahn said on Tuesday.

EU Commission President Ursula von der Leyen echoed those sentiments by saying on Twitter “(It is) Likely that the first Europeans will be vaccinated before end 2020.”

Germany, France, Italy and five other European states will coordinate the start of their vaccination campaigns, the countries’ health ministers said in a joint statement on Tuesday.

Rising infection rates and tighter lockdown measures in many European nations have added to the pressure on the EMA to act as quickly as possible and cast a shadow over the Christmas celebrations.

The EMA added any approval would come with a safety monitoring plan, manufacturing controls, an investigation plan for use in children and binding obligations by the manufacturers to provide more efficacy and safety data.

Britain was the first to approve the shot for emergency use on Dec. 3, followed by Canada on Dec. 9 and the U.S. Food and Drug Administration (FDA) on Dec. 11.

BioNTech reiterated it was on track deliver 50 million doses globally this year, for 25 million two-dose courses needed for immunisation.

(Reuters)

Top Stories

Action plan drafted for gradual unlocking of covid measures

Health experts advising the government on covid-19 have expressed cautious optimism that the strict restrictive measures currently in effect should be lifted by end...

Church and bagels to go: Biden’s first White House Sunday

President Joe Biden attended a church service in Washington's Georgetown neighbourhood and stopped for bagels at a hot pink shop named "Call Your Mother"...

Navalny supporters protest his arrest, in Moscow

Law enforcement officers detain a woman during a rally in support of jailed Russian opposition leader Alexei Navalny in Moscow, Russia January 23, 2021.

Police still looking for young man missing from mental hospital

Police are still looking for a 20-year-old man missing from Athalassa Psychiatric Hospital in Nicosia since Saturday afternoon. He is Theodoros Topouzides (top photo) from...

Mainly fine on Monday with high cloud in the afternoon

Mainly fine on Monday with high cloud in the afternoon and light to moderate north-easterly to south-easterly winds blowing at a force of 3...

Taste

Squash soup

Ingredients: 1 kg pumpkin, cut into small cubes, approximately 5 cups 2 medium (400g) sweet potatoes, cut into cubes, approximately 2 ½ cups 1 chopped leek, only...

Mezedes

No visit to Cyprus is complete without enjoying the traditional meal of many small dishes known as ‘meze’. This large feast, which has been a...

Prawns with fried cheese, barley shaped pasta

Put the barley shaped pasta into a small pan with salted water, bring to a boil and when tender, drain. Peal the prawns leaving...

Salmon and shrimp sheftalies

Mix all ingredients for tabbouli in a bowl and keep to one side so flavours can combine. Prepare the sheftalies: wash and soak the casing...